HOME >> BIOLOGY >> NEWS
New technology reduces noxious emissions

work together on shared technological and environmental concerns. USCAR formed PNGV with the federal government in 1993 to develop technologies for a new class of vehicles that will travel up to 80 miles on a gallon of gas while meeting reduced emissions levels for nitrogen oxides, carbon dioxide and hydrocarbons. New hybrid, light-duty diesel engines, such as those used in passenger cars and small trucks, already can meet target fuel economy requirements and actually emit less of the greenhouse gas carbon dioxide than gasoline engines. However, unlike gasoline engines, there is no technology that can sufficiently reduce nitrogen oxides in the lean burn exhaust typical of diesel vehicles. Nitrogen oxides cause air pollution.

Combining the plasma reactor concept with a catalyst was considered to be a left field approach but is now moving to the top of the PNGV list, said Steve Barlow, a PNNL chemical physicist. Six years ago, this field of non-thermal plasma-activated catalysis didnt exist, but it appears to have many advantages over competing technologies. For example, our catalysts arent poisoned by sulfur in the exhaust, which is a challenge for other catalytic technologies. Since the beginning, we have worked to improve both the electrical discharge designs and the catalyst performance; the resulting hybrid system is vastly more efficient than what we started out with, Barlow said. It is also much more rugged and reliable. One surprising result has been the relative ease with which we have been able to move from the laboratory bench to actual engine testing. This gives us confidence in the soundness of our approach.

Recent prototype reactor tests conducted on a diesel engine at DOEs Oak Ridge National Laboratory show a 50 percent reduction of NOx. Researchers are continuing to refine the plasma reactor system, which received a patent in 1999, to achieve even greater reduction of NOx. PNGV targets are a 90 percent reduction in NOx emission
'"/>

Contact: Gayle O'Donahue
gayle.odonahue@pnl.gov
509-375-2561
DOE/Pacific Northwest National Laboratory
22-Apr-2001


Page: 1 2 3

Related biology news :

1. Yale digital diagnostic technology is basis of new company, HistoRx Inc.
2. AACR applauds NCI initiative on nanotechnology
3. Rensselaer marks the opening of the center for biotechnology and interdisciplinary studies
4. New imaging technology at Joslin shown to detect early signs of type 1 diabetes
5. Researchers show how to assemble building blocks for nanotechnology
6. Jefferson Lab detector technology aids development of cystic fibrosis therapy
7. National Academies Advisory: Sept. 18-19 Nanotechnology Conference
8. New diagnostic technology helps justify earlier cataract surgery
9. New textbook introduces students to the foundations, applications of nanotechnology
10. UK biotechnology business plan competition now open to students in the US and Canada
11. The future of nanotechnology

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/7/2017)... SALT LAKE CITY , March 7, 2017 /PRNewswire/ ... solutions that help top global companies identify the best ... Leonard as Chief Sales Officer (CSO) and ... and Kucer,s appointments round out a seasoned executive team poised ... year and beyond, building on a year of record ...
(Date:3/2/2017)... Australian stem cell and regenerative medicine company, ... an agreement with the Monash Lung Biology Network, a ... and Department of Pharmacology at Monash University, ... to support the use of Cymerus™ mesenchymal stem cells ... Asthma is a chronic, long term lung condition recognised ...
(Date:2/27/2017)...   Strategic Cyber Ventures , the industry,s first ... $3.5 million investment in  Polarity , the first commercial ... DC based and is led by cybersecurity veterans ... Ron Gula , also a longtime cybersecurity veteran and ... series A round of funding. This new funding will ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... March 23, 2017 NetworkNewsWire Editorial Coverage  ... Cancer ... significant strain on health care systems, in terms of costs ... so too does the development of innovative and efficient therapies ... Among the many types of cancer treatments, a growing number ...
(Date:3/22/2017)... , March 22, 2017 Regeneron Pharmaceuticals, Inc. (NASDAQ: ... Genetics Center (RGC), U.K. Biobank and GSK to generate genetic ... Biobank resource. The initiative will enable researchers to gain valuable ... for a wide range of serious and life threatening diseases. ... Genetic ...
(Date:3/22/2017)... March 22, 2017 Oramed Pharmaceuticals Inc. ... www.oramed.com ), a clinical-stage pharmaceutical ... delivery systems, announced today that Dr. Miriam ... a presentation titled, "Oral Insulin for Diabetes Treatment: ... Healthtech Institute,s Oligonucleotide and Peptide Therapeutics (OPT) Boston Conference in ...
(Date:3/22/2017)... , March 22, 2017   Boston Biomedical ... cancer therapeutics designed to target cancer stemness pathways, today ... S. Andrews as Chief Executive Officer, effective April ... Chiang J. Li , M.D., FACP, who has ... years ago. Under his leadership, Boston Biomedical has grown ...
Breaking Biology Technology:
Cached News: